Preclinical evaluation of antimicrobial nanodrugs / Juan Bueno.
2020
RM267
Linked e-resources
Linked Resource
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
Preclinical evaluation of antimicrobial nanodrugs / Juan Bueno.
Author
ISBN
9783030438555 (electronic book)
3030438554 (electronic book)
9783030438548
3030438546
3030438554 (electronic book)
9783030438548
3030438546
Publication Details
Cham : Springer, 2020.
Language
English
Description
1 online resource (125 pages).
Item Number
10.1007/978-3-030-43
10.1007/978-3-030-43855-5 doi
10.1007/978-3-030-43855-5 doi
Call Number
RM267
Dewey Decimal Classification
615.7/92
Summary
Translational medicine addresses the gap between research and the clinical application of new discoveries. To efficiently deliver new drugs to care centers, a preclinical evaluation, both in vitro and in vivo, is required to ensure that the most active and least toxic compounds are selected as well as to predict clinical outcome. Antimicrobial nanomedicines have been shown to have higher specificity in their therapeutic targets and the ability to serve as adjuvants, increasing the effectiveness of pre-existing immune compounds. The design and development of new standardized protocols for evaluating antimicrobial nanomedicines is needed for both the industry and clinical laboratory. These protocols must aim to evaluate laboratory activity and present models of pharmacokinetic-pharmacodynamic and toxicokinetic behavior that predict absorption and distribution. Likewise, these protocols must follow a theranostics approach, be able to detect promising formulations, diagnose the infectious disease, and determine the correct treatment to implement a personalized therapeutic behavior. Given the possibilities that nanotechnology offers, not updating to new screening platforms is inadequate as it prevents the correct application of discoveries, increasing the effect of the valley of death between innovations and their use. This book is structured to discuss the fundamentals taken into account for the design of robust, reproducible and automatable evaluation platforms. These vital platforms should enable the discovery of new medicines with which to face antimicrobial resistance (RAM), one of the great problems of our time.
Bibliography, etc. Note
Includes bibliographical references and index.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Source of Description
Description based on print version record.
Series
Nanotechnology in the life sciences.
Available in Other Form
Linked Resources
Record Appears in